ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,341, issued on Oct. 27, was assigned to BIOSION INC. (Nanjing, China). "Antibodies binding BCMA and uses thereof" was invented by Mingjiu C... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,342, issued on Oct. 27, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Methods of treating multiple myeloma with bispec... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,343, issued on Oct. 27, was assigned to ACTINIUM PHARMACEUTICALS INC. (New York). "Humanized anti-CD45 antibodies" was invented by Lequn Zh... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,344, issued on Oct. 27, was assigned to Akeso Biopharma Inc. (Zhongshan, China). "Anti-CD73 antibody and use thereof" was invented by Zhong... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,345, issued on Oct. 27, was assigned to CHUGAI SEIYAKU K.K. (Tokyo). "Immunoactivating antigen-binding molecule" was invented by Tomoyuki I... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,346, issued on Oct. 27, was assigned to BIOTHEUS INC. (Zhuhai, China). "Anti-CEACAM5 monoclonal antibody and preparation method thereof and... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,347, issued on Oct. 27, was assigned to NOILE-IMMUNE BIOTECH INC. (Tokyo). "Isolated immune cell expressing a receptor, interleukin-7, and ... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,348, issued on Oct. 27, was assigned to argenx BV (Ghent, Belgium). "FcRn/antigen-binding molecules and methods of use" was invented by Vla... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,349, issued on Oct. 27, was assigned to William Robert Arathoon Living Trust Dated August 29, 2016 (Tiburon, Calif.). "Anti ABCC1 antibodie... Read More
ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,350, issued on Oct. 27, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Antibodies binding to CD3 and FOLR1" was invented by ... Read More